The oral IRAK4 inhibitors zabedosertib and BAY1830839 suppress local and systemic immune responses in a randomized trial in healthy male volunteers
Article in Clinical and Translational Science (March 2024)
The most recent citing publications are shown below. View all 34 publications that cite this research output on Dimensions.
Article in Clinical and Translational Science (March 2024)
Article in Toxin Reviews (March 2024)
Article in BMC Complementary Medicine and Therapies (January 2024)